SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks1Spatial Holdings Regulatory News (SPA)

  • This share is currently suspended. It was suspended at a price of 72.80
  • There is currently no data for SPA

Form 8 (DD) - Xploite PLC

23 Apr 2010 16:53

RNS Number : 7341K
Xploite PLC
23 April 2010
 



FORM 8 (DD)

 

PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS)

Rules 8.1, 8.2 and 8.4 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Identity of the party to the offer or person acting in concert making the disclosure:

Ian Smith (Chief Executive)

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Xploite plc

(d) Status of person making the disclosure:

e.g. offeror, offeree, person acting in concert with the offeror/offeree (specify name of offeror/offeree)

Offeree

(e) Date dealing undertaken:

23/04/10

(f) Has the party previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

NO

 

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

4,415,403

19.2%

(2) Derivatives (other than options):

(3) Options and agreements to purchase/sell:

 

TOTAL:

4,415,403

19.2%

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities (including directors' and other executive options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

3. DEALINGS BY THE PERSON MAKING THE DISCLOSURE

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

Ordinary shares

Exercise of Options over new shares

 

344,828

29p

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer or person acting in concert making the disclosure and any other person:

If there are no such agreements, arrangements or understandings, state "none"

 

none

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer or person acting in concert making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

none

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

23 April 2010

Contact name:

Ian Smith

Telephone number:

+44 (0) 870 737 2001

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DCCBUGDSBUDBGGX
Date   Source Headline
14th May 20197:00 amRNSFinal results for the year ended 31 January 2019
13th May 20192:50 pmRNSHolding(s) in Company
10th May 201911:23 amRNSHolding(s) in Company
8th May 20197:00 amRNSPlacing, Acquisition & Agreement with Esri
15th Mar 20197:00 amRNSTransfer of FTSE sector classification to Software
7th Mar 20197:00 amRNSTrading Update
5th Mar 20192:51 pmRNSHolding(s) in Company
20th Feb 20197:00 amRNS1Spatial Awarded Significant Contract
19th Feb 20197:00 amRNSAmendment to Enables IT Disposal Agreement
18th Jan 20197:00 amRNS1Spatial Awarded Significant Contracts
12th Dec 201811:37 amRNSDirector Shareholding
29th Nov 20189:30 amRNSHolding(s) in Company
1st Nov 20186:13 pmRNSHolding(s) in Company
30th Oct 20189:33 amRNSHolding(s) in Company
23rd Oct 20187:00 amRNSInterim Results
2nd Oct 20187:00 amRNSNotice of Results
20th Sep 20183:43 pmRNSDirector Share Purchase
7th Sep 201810:41 amRNSDirector Share Purchase
7th Sep 20187:00 amRNSDirector Share Purchase
5th Sep 20187:00 amRNSNew Long-Term Incentive Plan and Grant of Options
31st Aug 20184:56 pmRNSTotal Voting Rights
24th Aug 201810:06 amRNSDirector Share Purchase
23rd Aug 20182:48 pmRNSHolding(s) in Company
20th Aug 20183:19 pmRNSResult of General Meeting
31st Jul 20187:00 amRNSPosting of Circular & Related Party Transactions
26th Jul 20185:12 pmRNSResult of Placing
26th Jul 201811:06 amRNSClose of Accelerated Bookbuild
26th Jul 20187:00 amRNSLaunch Of Placing Via Accelerated Bookbuild
24th Jul 20181:00 pmRNSResult of AGM
10th Jul 20187:00 amRNSDirector Appointment
2nd Jul 20187:00 amRNSReport and Accounts and Notice of AGM
22nd May 20187:00 amRNSFinal results for the year ended 31 January 2018
9th May 20187:00 amRNSNotice of Results
3rd Apr 20187:00 amRNS1Spatial Awarded Significant Contract
15th Mar 20187:00 amRNSDirectorate Change
15th Mar 20187:00 amRNSDisposal of Enables IT
15th Mar 20187:00 amRNSTrading Update
11th Jan 20184:00 pmRNSHolding(s) in Company
10th Jan 20183:24 pmRNSHolding(s) in Company
9th Jan 20187:00 amRNS1Spatial Awarded US State Contract
4th Dec 20179:30 amRNSHolding(s) in Company
29th Nov 20176:23 pmRNSReplacement: Holding(s) in Company
29th Nov 201712:00 pmRNSHolding(s) in Company
24th Oct 201712:45 pmRNSHolding(s) in Company
10th Oct 20177:01 amRNSInterim Results
10th Oct 20177:00 amRNSDirectorate Changes
19th Sep 201711:24 amRNSHolding(s) in Company
14th Sep 20171:54 pmRNSNotice of Interim Results
14th Sep 20179:58 amEQSEdison Investment Research Limited: Edison issues outlook on 1Spatial (SPA)
14th Sep 20177:00 amRNSUS Contract Wins

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.